The effects of intravenous remifentanil on umbilical artery serum-derived exosomes in parturients undergoing epidural anesthesia: a randomized trail

• Published in: BMC pregnancy and childbirth 2023-01, Vol.23 (1), p.29-29
• Main Authors: Wang, Liangrong, Li, Juan, Yang, Xiaodan, Xiong, Yicheng, Wang, Zilu, Li, Li, Li, Xinmiao, Zhang, Hang, Chen, Yong, Lin, Lina, Xiong, Xiangqing
• Format: Article
• Language: English
• Subjects: Analgesia; Analgesics, Opioid - therapeutic use; Anesthesia, Epidural - methods; Cesarean Section; Exosomes; Female; Humans; Infant, Newborn; Infusions, Intravenous; Piperidines; Pregnancy; Remifentanil; Repeated cesarean section; Umbilical Arteries; Visceral Pain - drug therapy
• ISSN: 1471-2393
• DOI: 10.1186/s12884-023-05360-8

Umbilical artery serum-derived exosomes (UEs) serve as messengers for maternal-fetal information exchange and cellular regulation. Intravenous remifentanil could be considered as an effective adjunct to epidural anesthesia in providing a favorable analgesia effect for cesarean section (C-section), but its effects on UEs are currently unknown. From 01/12/2021 to 30/06/2022, eligible parturients scheduled for repeated C-section at the First Affiliated Hospital of Wenzhou Medical University were randomized to receive either an intravenous bolus (0.15 μg/kg) followed by a continuous infusion (0.075 μg/kg/min) of remifentanil or normal saline throughout the procedure. The primary outcome was the number of UEs. Secondary outcomes included the size and protein amount of UEs, the vital signs, visceral pain score, sedation score, maternal satisfaction score, Apgar score, the incidence of neonatal asphyxia, umbilical arterial pH, and the presence of complications. Nanoparticle tracking analysis indicated similar size of UEs between the two groups, but the number and protein amount of UEs were increased in the remifentanil group  compared to the control group (P